A randomised controlled trial of bumetanide in the treatment of autism in children

Éric Lemonnier(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Yehezkel Ben‐Ari(Neurochlore (France)), Marine Grandgeorge(Centre Hospitalier Régional Universitaire de Brest), Céline Degrez(Centre Hospitalier Régional Universitaire de Brest), Roman Tyzio(Inserm), Nouchine Hadjikhani(Harvard University Press), F. Josse(Centre Hospitalier Régional Universitaire de Brest), M Phelep(Centre Hospitalier Régional Universitaire de Brest)
Translational Psychiatry
December 11, 2012
10.1038/tp.2012.124
Cited by 310

Related Papers

X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family
|The American Journal of Human Genetics|2004|762
Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
|Science|2014|587
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
|Translational Psychiatry|2017|210
The missing link: Enhanced functional connectivity between amygdala and visceroceptive cortex in migraine
|Cephalalgia|2013|169
Modulation of brainstem activity and connectivity by respiratory-gated auricular vagal afferent nerve stimulation in migraine patients
|Pain|2017|146